Ethnic differences in the relationship of prediabetes with the presence of target-organ disease

Diabetes and Metabolism

Volumn 37, Issue 5, 2011, Pages 403-409

  Player, M S ^a   Diaz, V A ^a   Mainous, III ^a   Gregorie, S H ^a   Knoll, M E ^a   Everett, C J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Atherosclerosis; Coronary artery calcification; Ethnic differences; Prediabetes

Indexed keywords

ADULT; AGED; ALBUMINURIA; ANKLE BRACHIAL INDEX; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CAUCASIAN; CORONARY ARTERY CALCIFICATION; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; ETHNIC DIFFERENCE; FEMALE; GLUCOSE BLOOD LEVEL; HISPANIC; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NEGRO; RISK ASSESSMENT; TARGET ORGAN;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ALBUMINURIA; ANKLE BRACHIAL INDEX; CAROTID STENOSIS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 80555123334     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2010.12.009     Document Type: Article

References (42)

1. Engelgau M.M., Geiss L.S., Saaddine J.B., Boyle J.P., Benjamin S.M., Gregg E.W., et al. The evolving diabetes burden in the United States. Ann Intern Med 2004, 140:945-950.
2. Mainous A.G., Baker R., Koopman R.J., Saxena S., Diaz V.A., Everett C.J., et al. Impact of the population at risk of diabetes on projections of diabetes burden in the United States: an epidemic on the way. Diabetologia 2007, 50:934-940.
3. Steinbrook R. Facing the diabetes epidemic-mandatory reporting of glycosylated hemoglobin values in New York City. N Engl J Med 2006, 345:545-548.
4. Koopman R.J., Mainous A.G., Diaz V.A., Geesey M.E. Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988-2000. Ann Fam Med 2005, 3:60-63.
5. Cowie C.C., Rust K.F., Byrd-Holt D.D., Eberhardt M.S., Flegal K.M., Engelgau M.M., et al. Prevalence of diabetes and impaired fasting glucose in adults in the US population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 2006, 29:1263-1268.
6. Duncan G.E. Prevalence of diabetes and impaired fasting glucose levels among US adolescents: National Health and Nutrition Examination Survey, 1999-2002. Arch Pediatr Adolesc Med 2006, 160:523-528.
7. Gerstein H.C., Yusuf S., Bosch J., Pogue J., Sheridan P., Dinccag N., et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial. Lancet 2006, 368:1096-1105.
8. Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403. Diabetes Prevention Program Research Group.
9. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009, 374:1677-1686. Diabetes Prevention Program Research Group.
10. Lilly M., Godwin M. Treating pre-diabetes with metformin: systematic review and meta-analysis. Can Fam Physician 2009, 55:363-369.
11. American Diabetes Association. Pre-Diabetes FAQs. 2010. Available from: http://www.diabetes.org/diabetes-basics/prevention/pre-diabetes/pre-diabetes-faqs.html.
12. Benjamin S.M, Valdez R., Geiss L.S., Rolka D.B., Venkat Narayan K.M. Estimated number of adults with pre-diabetes in the United States in 2000: ppportunities for prevention. Diabetes Care 2003, 26:645-649.
13. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet Med 2007, 24:137-144. Diabetes Prevention Program Research Group.
14. Santaguida PL, Balion C, Hunt D, Morrison K, Gerstein H, Raina P, et al. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. Summary, Evidence Report/Technology Assessment No. 128. (Prepared by the McMaster Evidence-based Practice Center under Contract No. 290-02-0020). 2005 AHRQ Pub. No. 05-E026-1.
15. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 344:393-403. The Diabetes Prevention Program Research Group.
16. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., et al. The Finnish Diabetes Prevention Study group; prevention of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2001, 344:1343-1350.
17. Wingard D.L., Barrett-Connor E.L., Scheidt-Nave C., McPhillips J.B. Prevalence of cardiovascular and renal complications in older adults with normal or impaired glucose tolerance or NIDDM: a population-based study. Diabetes Care 1993, 1022-1025.
18. Levitzky Y.S., Pencina M.J., D'Agostino R.B., Meigs J.B., Murabito J.M., Vasan R.S., et al. Impact of impaired fasting glucose on cardiovascular disease: the Framingham heart Study. J Am Coll Cardiol 2008, 51:264-270.
19. Ford E.S., Zhao G., Li C. Pre-Diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol 2010, 55:1310-1317.
20. Plantinga L.C., Crews D.C., Coresh J., Miller E.R., Saran R., Yee J., et al. Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or pre-diabetes. Clin J Am Soc Nephrol 2010, 5:673-682.
21. Lavery L.A., van Houtum W.H., Ashry H.R., Armstrong D.G., Pugh J.A. Diabetes-related lower-extremity amputations disproportionately affect Blacks and Mexican Americans. South Med J 1999, 92:593-599.
22. Ness J., Nassimiha D., Feria M.I., Aronow W.S. Diabetes mellitus in older African-Americans, Hispanics, and whites in an academic hospital-based geriatrics practice. Coron Artery Dis 1999, 10:343-346.
23. Harris M.I., Klein R., Cowie C.C., Rowland M., Byrd-Holt D.D. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A US population study. Diabetes Care 1998, 21:1230-1235.
24. Budoff M.J., Yang T.P., Shavelle R.M., Lamont D.H., Brundage B.H. Ethnic differences in coronary atherosclerosis. J Am Coll Cardiol 2002, 39:408-412.
25. Lee K.K., Fortmann S.P., Fair J.M., Iribarren C., Rubin G.D., Varady A., et al. Insulin resistance independently predicts the progression of coronary artery calcification. Am Heart J 2009, 157:939-945.
26. Orakzai S.H., Orakzai R.H., Nasir K., Santos R.D., Edmundowicz D., Budoff M.J., et al. Subclinical coronary atherosclerosis: ethnic profiling is necessary!. Am Heart J 2006, 152:819-827.
27. Nasir K., Shaw L.J., Liu S.T., Weinstein S.R., Mosler T.R., Flores P.R., et al. Ethnic differences in the prognostic value of coronary artery calcification for all-cause mortality. J Am Coll Cardiol 2007, 50:953-960.
28. Bild D.E., Bluemke D.A., Burke G.L., Detrano R., Diez Roux A.V., Folsom A.R., et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002, 156:871-881.
29. Greenland P., Bonow R.O., Brundage B.H., Budoff M.J., Eisenberg M.J., Grundy S.M., et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation clinical expert consensus task force (ACCF/AHA writing committee to update the 2000 expert consensus document on electron beam computed tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2007, 49:378-402.
30. Cheng Y.J., Church T.S., Kimball T.E., Nichaman M.Z., Levine B.D., McGuire D.K., et al. Comparison of coronary artery calcium detected by electron beam tomography in patients with to those without symptomatic coronary heart disease. Am J Cardiol 2003, 92:498-503.
31. Church T.S., Levine B.D., McGuire D.K., Lamonte M.J., Fitzgerald S.J., Cheng Y.J., et al. Coronary artery calcium score, risk factors, and incident coronary heart disease events. Atherosclerosis 2007, 190:224-231.
32. Budoff M.J., McClelland R.L., Nasir K., Greenland P., Kronmal R.A., Kondos G.T., et al. Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J 2009, 158:554-561.
33. Alexopoulos N., Raggi P. Calcification in atherosclerosis. Nat Rev Cardiol 2009, 6:681-688.
34. Yaghoubi S., Tang W., Wang S., Reed J., Hsiai J., Detrano R., et al. Offline assessment of atherosclerotic coronary calcium from electron beam tomograms. Am J Cardiac Imag 1995, 9:231-236.
35. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte M., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990, 15:827-832.
36. Folsom A.R., Kronmal R.A., Detrano R.C., O'Leary D.H., Bild D.E., Bluemke D.A., et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 2008, 168:1333-1339.
37. Millen B.E., Quatromoni P.A., Nam B.H., Pencina M.J., Polak J.F., Kimokoti R.W., et al. Compliance with expert population-based dietary guidelines and lower odds of carotid atherosclerosis in women: the Framingham Nutrition Studies. Am J Clin Nutr 2005, 82:174-180.
38. Kobayashi H., Giles J.T., Polak J.F., Blumenthal R.S., Leffell M.S., Szklo M., et al. Atherosclerosis in rheumatoid arthritis is artery-specific. J Rheumatol 2010, 37:730-739.
39. Flack J.M., Ferdinand K.C., Nasser S.A. Epidemiology of hypertension and cardiovascular disease in African-Americans. J Clin Hypertens 2003, 5(1 Suppl. 1):5-11.
40. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998, 317:703-713. Prospective Diabetes UK Study Group.
41. McMurray J.J., Holman R.R., Haffner S.M., Bethel M.A., Holzhauer B., Hua T.A., et al. Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med 2010, 362:1477-1490.
42. Holman R.R., Haffner S.M., McMurray J.J., Bethel M.A., Holzhauer B., Hua T.A., et al. Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med 2010, 362:1463-1476.